Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease
New England Journal of Medicine. This randomized, double-blind placebo-controlled study examined 78 seropositive and 51 seronegative patients who had previously received about 30 days of IV ceftriaxone for Lyme disease, but still had symptoms. Includes charts, tables.